Tilray sees second-quarter revenue growth despite cannabis slowdown
Tilray Brands Inc. (NASDAQ: TLRY) topped Wall Street’s revenue expectations Friday as the company continues beefing its beer business amid sluggish marijuana sales. The company’s fiscal second-quarter revenue rose 9% to $211 million for the quarter ended Nov. 30, eclipsing analysts’ average estimate of $207.8 million, according to financial data from Yahoo Finance. The company […]
cbdMD posts lower annual sales, mixed fourth quarter
Charlotte-based cbdMD Inc. (NYSE American: YCBD) saw annual revenue drop 19%, but the company significantly reduced its losses as it pushes toward profitability, according to financial results released Wednesday after U.S. markets closed. Net sales fell to $19.5 million for fiscal year 2024, which ended Sept. 30, from $24.2 million the previous year. However, the […]
Organigram tops estimates, expands international reach ahead of major deal
Organigram Holdings Inc. (Nasdaq: OGI) beat analyst expectations Wednesday off the heel of a major acquisition announcement, despite remaining in the red for now. The Toronto-based producer posted fiscal fourth-quarter revenue of C$44.7 million that beat Yahoo Finance’s average estimate of C$39.12 million. Still, the company reported a net loss of C$5.4 million in its […]
Bright Green still has no plants, but the CEO is well compensated
Bright Green Corporation (OTC: BGXX) quietly released its earnings in November as the company continues to insist it is in the building stage of its DEA-approved cannabis facility. Bright Green still has no revenue to report and was delisted from the Nasdaq exchange this past fall. The company’s DEA Manufacturing Registration and its DEA Importer […]
Entourage Health revenues grow as it stays one step ahead of lenders
On Friday, Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) released its financial results for the three months ending September 30, 2024. Entourage reported total revenue increased by 11% to C$13.6 million over last year’s C$12.2 million. Entourage trimmed its losses to C$8.3 million from last year’s loss of C$9.9 million. Behind the revenue CFO Vaani Maharaj […]
Greenway posts 52% revenue growth in Q2 despite production challenges
Greenway Greenhouse Cannabis Corp. (CSE: GWAY) reported a 52% year-over-year increase in second quarter revenue, though production challenges led to higher costs and a wider net loss. The Ontario-based cannabis cultivator generated net revenue of C$1.8 million in its second quarter ending Sept. 30, up from C$1.2 million in the same period last year, according […]
POSaBIT reports third-quarter loss despite payment platform growth
POSaBIT Systems Corp. (CSE: PBIT) (OTC: POSAF) reported a $2.1 million loss in its third quarter even though adoption of its new payment platform and expanded merchant base has grown. The cannabis fintech posted revenue of $4.1 million for the period ending Sept. 30, down 4% from the second quarter. The steeper 70% decline from […]
Simply Solventless third-quarter revenue jumps with CannMart acquisition
Simply Solventless Concentrates Ltd. (TSXV: HASH) reported its third-quarter earnings for the period ending Sept. 30. Revenue rose to C$7.1 million versus last year’s third-quarter revenue of C$1.4 million. SSC told investors that the latest results include the operations of the CannMart acquisition, which closed on Sept. 12. The results do not include the operations […]
Herbal Dispatch sees 120% revenue growth as export sales surge
Herbal Dispatch Inc. (CSE: HERB) reported a 120% increase in quarterly revenue, driven by expanding international export operations and growing domestic recreational sales. The Vancouver-based company generated gross revenue of C$3.3 million in the third quarter ending Sept. 30, up from C$1.5 million a year earlier, according to financial results released Wednesday. Year-to-date revenue reached […]
Filament Health revenue slides 94% as cash reserves dwindle
Vancouver-based Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) saw its cash reserves continue to decline as third-quarter revenue plummeted to $19,021, from $337,470 in the same period last year, according to financial results Thursday. The clinical-stage psychedelic drug development firm ended September with $878,717 in cash and cash equivalents, less than half of the […]